Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chin-Feng Tsai
Variations of the Proprotein Convertase Subtilisin/Kexin Type 9 Gene in Coronary Artery Disease
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Related publications
Lipoprotein(a) and Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Lipoprotein(a) and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors
Clinical Research in Cardiology Supplements
Nuclear Medicine
Radiology
Molecular Biology
Structural Biology
Imaging
Medicine
PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Cost Effectiveness of Proprotein Convertase Subtilisin/ Kexin Type 9 (PCSK9) Inhibitors
Cardiovascular Disorders and Medicine
Association Between Plasma Proprotein Convertase Subtisilin/Kexin Type 9 Concentration and Coronary Artery Calcification
Annals of Clinical Biochemistry
Medicine
Clinical Biochemistry
Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK-9) Inhibitors Induced Liver Injury - A Retrospective Analysis
Journal of Community Hospital Internal Medicine Perspectives
Internal Medicine
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Alzheimer’s Disease: A Genetic and Proteomic Multi-Cohort Study
PLoS ONE
Multidisciplinary
Proprotein Convertase Subtilisin Kexin Type 9 Null Mice Are Protected From Postprandial Triglyceridemia
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Deficiency Is Protective Against Venous Thrombosis in Mice
Scientific Reports
Multidisciplinary
